FDA approves weight-loss drug to treat sleep apnea
The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency green-lighted Eli Lilly’s Zepbound drug for the use,
F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea
Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the common sleep disorder.
8hon MSN
The U.S. Food and Drug Administration reports that contaminated cucumbers are linked to 100 salmonella cases across 23 states ...
The U.S. Food and Drug Administration (FDA) now classifies eggs as a “healthy, nutrient-dense" food, according to a new ...
The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...
A new rule from the Food and Drug Administration (FDA) will update what it means for food to be labeled “healthy” for the ...
The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries.
The FDA has issued a slew of recalls in the last three weeks, with many products containing cucumbers and other vegetables ...
Earlier this month, the US Food and Drug Administration (FDA) issued new draft guidance regarding their accelerated approval pathway for new drugs ...
The Maharashtra Public Service Commission (MPSC) has uploaded the results for the Food and Drug Administration (FDA) Services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback